Funding for this research was provided by:
Sichuan Province Science and Technology Support Program (2020YFS0269)
Received: 8 January 2022
Accepted: 16 February 2023
First Online: 24 February 2023
: The Ethics Committee on Biomedical Research, West China Hospital of Sichuan University, approved the study protocol (Approval code: NO. 2020–367). The study was also registered in the Chinese Clinical Trial Registry (registration ID: ChiCTR2100047229). Before randomisation, all participants will be asked to provide written informed consent.
: The authors declare that they have no competing interests.